Tag Archives: j&j

Featured Stories

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

J&J Faces 4th Talcum Powder Ovarian Cancer Trial in St. Louis

J&J Faces Talcum Powder Ovarian Cancer Trial in St. Louis

J&J Talcum Powder Allegedly Caused Ovarian Cancer Johnson & Johnson is facing another talcum powder ovarian cancer trial in St. Louis, where a number of lawsuits allege that the product contributed to ovarian cancer. The case is the fourth talcum … Continue reading

Posted in Health Concerns, Toxic Substances | Tagged , , , , |

Plaintiff Awarded $70 Million in Talc Lawsuit Lead to More Suits Filed

Plaintiff Awarded $70M in Talc Case Lead to More Suits Filed

A plaintiff, recently was awarded $70 million in a talcum powder lawsuit against Johnson & Johnson (J&J), the manufacturer that allegedly was aware of a potential risk between talcum powder and ovarian cancer but neglected to alert consumers regarding that … Continue reading

Posted in Defective Products | Tagged , , , , |

Johnson & Johnson’s Ethicon Recalls Physiomesh Hernia Mesh

J&J’s Ethicon Recalls Physiomesh Hernia Mesh

Physiomesh Recalled Due to High Failure Rates Ethicon, a Johnson & Johnson unit, is recalling its Physiomesh because studies show that patients are undergoing higher rates of revision surgery compared to other mesh devices. Physiomesh flexible composite hernia mesh is … Continue reading

Posted in Defective Medical Devices | Tagged , , , , , |

Court Rejects J&J Bid to Toss Talcum Powder Trial

Court Rejects J&J Bid to Toss Talcum Powder Trial

A talcum powder lawsuit is currently on trial in St. Louis, Missouri. The plaintiff in the lawsuit is a 63-year-old California woman who suffers from stage 4 ovarian cancer. She alleges that using talcum powder for feminine hygiene for 44 … Continue reading

Posted in Defective Products, Health Concerns, Toxic Substances | Tagged , , , , , , |

Talcum Powder Lawsuits Continue to Pile Up

Talcum Powder Lawsuits Continue to Pile Up

Johnson & Johnson is faced with a growing number of lawsuits from women who allege that Johnson’s Baby Powder and Shower to Shower body powder are responsible for their ovarian cancer. The lawsuits include wrongful death lawsuits from the families … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances | Tagged , , , , |

Jurors Told that J&J Obscured Risperdal Gynecomastia Data

Jurors Told that J&J Obscured Risperdal Gynecomastia Data

A number of lawsuits have been filed over Risperdal, an antipsychotic medication marketed by Johnson & Johnson’s Janssen Pharmaceuticals. Plaintiffs allege that the drug caused gynecomastia, or abnormal breast growth, in adolescent boys. The suits allege that J&J knew about … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

Expert Testimony: J&J Talcum Powder Should have Carried Cancer Warning Since 1982

J&J Talcum Powder Should Have Had Cancer Warning Since 1982

During an expert testimony, jurors heard that Johnson & Johnson should have placed an ovarian cancer warning on its talcum powder products since 1982. The expert testimony was given by David C. Steinberg, who runs a topical over-the-counter drug compliance … Continue reading

Posted in Defective Products, Toxic Substances | Tagged , , , , , |

Talcum Powder Plaintiff Files Wrongful Death Lawsuit Against J&J

Talcum Powder Plaintiff Files Wrongful Death Suit Against J&J

Johnson & Johnson is facing a lawsuit filed on behalf of a woman whose daughter died of ovarian cancer, allegedly due to using talcum powder for feminine hygiene. The wrongful death lawsuit alleges that J&J failed to disclose that using … Continue reading

Posted in Defective Products | Tagged , , , , |

Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement

Xarelto Plaintiffs Hope for Similar Pradaxa Settlement

The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , , , , , |

J&J Talcum Powder Lawsuit Verdict Upheld, J&J Appeals

J&J Talcum Powder Lawsuit Verdict Upheld, J&J Appeals

A $55 million judgment awarded in a 2016 talcum powder lawsuit has been upheld, according to an Order dated September 9th. The Missouri 22nd Judicial Circuit Court for St. Louis City denied Johnson & Johnson’s post-trial motions which included a … Continue reading

Posted in Consumer Fraud, Defective Products, Health Concerns, Toxic Substances | Tagged , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.